Jounce’s Cin­derel­la sto­ry now in­cludes a $102M IPO chap­ter

Every up-and-com­ing biotech in the in­dus­try likes to dream about do­ing that one big, trans­for­ma­tion­al deal that brings the spot­light and some rock star mar­ket …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.